Female mammals make a surfeit of oocytes when they are fetuses, but lose many of them by birth-humans, for instance, jettison about 80 percent. The gametes that survive comprise the primordial follicle reserve, with consequences for fertility, particularly in the fourth decade of life. A new study in mice examines why and how this early fetal loss happens, suggesting that high levels of retrotransposon activity lead to oocyte death.
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The genomes of mice and humans contain thousands of LINE1 retrotransposons-they make up about 10 percent of the mouse genome. Throughout most of an animal's lifespan, these retrotransposons are methylated and silent. But during germ cell development, the genome is stripped of its methyl marks-a process known to awaken LINE1 elements. Various mechanisms have evolved to counteract LINE1 jumpiness; in the male germline, for instance, PIWI-interacting RNAs keep transposons under control. But researchers have not identified a similar major role for PIWI-interacting RNAs in the female germline.
The new study, by Safia Malki et al., supports a distinct mechanism, providing evidence that oocytes with high levels of retrotransposon activity are culled. To show this, the researchers experimentally manipulated LINE expression. For instance, mice deficient in a gene involved in transposon silencing had elevated levels of LINE activity-and they had elevated levels of fetal oocyte attrition. The oocytes in these mice also had higher levels of doublestranded DNA breakage and meiotic defects during meiosis I, consistent with previous studies showing that high LINE activity affects DNA integrity. The researchers also performed the converse experiment, quelling LINE1 activity by applying AZT, a reverse transcriptase inhibitor. They found that the drug promoted oocyte survival.
These findings dovetailed with another key observation: some fetal oocytes seem to have higher levels of LINE activity than others, as indicated by experiments examining levels of a key LINE1 encoded protein. The study suggests that such oocytes are likely to be killed off. The researchers' observations also suggest that LINE1 activity may contribute to meiotic chromosome segregation errors during oocyte development. Extra copies of the VAMP7 gene, encoding a protein that alters steroid receptor action, underlie some genitourinary defects in newborn boys.
Male genitourinary development is very sensitive to the levels of androgens and estrogens in the fetus. Factors that may affect hormone action, including androgen receptor mutations and environmental toxicants, can result in congenital genitourinary defects such as hypospadias (misplacement of the urethra) and cryptorchidism (failure of testes to descend into the scrotum). These anomalies are common birth defects in newborns.
Mounia Tannour-Louet et al. had previously shown a link between human sexual development disorders and de novo copy number variants-gains or losses of genomic material that had arisen spontaneously and were not inherited from either parent. In the new study, the researchers honed in on one such variant-a copy number gain in a region encompassing only the VAMP7 gene. The researchers found that VAMP7 gains were present in 1.35 percent of patients (4 out of 296), accounting for a higher frequency of such disorders than found in other linked mutations that have been identified by a variety of research groups.
The researchers generated mice with extra copies of Vamp7 and showed that they had defects similar to those observed in the boys with masculinization disorders. They also had sperm production deficiencies and subfertility with aging. Further analysis of these mice, along with cell-based experiments, showed that high levels of VAMP7 resulted in elevated cellular levels of ESR1 (estrogen receptor a). As a result, the expression of ESR1 transcriptional targets was elevated and androgen receptor signaling was modestly blunted. Previous studies have implicated some of these ESR1-regulated genes in human hypospadias.
Exactly how VAMP7 affects ESR1 activity is unclear, but VAMP7 is known to be involved in proper membrane fusion and transport of proteins between organelles. The researchers showed that VAMP7 colocalized with ESR1 in the presence of its ligand, 17b-estradiolperhaps affecting the stability of ESR1. Sperm bind to the N-terminus of ZP2, a major component of the extracellular zona pellucida that surrounds the oocyte, according to a new study of fertilization in mice and humans. The findings help clarify the longstanding question of how sperm recognize eggs.
The zona pellucida consists of four glycoproteins in humans (ZP 1, 2, 3, and 4), and three proteins in mice (ZP 1, 2, and 3). Previous studies have suggested that sperm recognize ZP2, and mice lacking ZP2 are sterile-but such mice also do not form a zona pellucida, which has complicated the analysis. In the new study, Matteo Avella et al. generated transgenic mice that express human ZP4; such mice lack ZP2, but have a zona pellucida. Mouse sperm did not bind to the zona matrix in vitro, and female mice were sterile.
The researchers also examined mice with a humanized zona pellucida, expressing only human ZP proteins. They found that transgenic mice expressing human ZP1, 3, and 4, but not ZP2, formed a zona pellucida-but human sperm did not bind to it. The researchers also showed that ZP2 is sufficient for sperm recognition in artificial insemination experiments in transgenic mice. Human sperm bound to the zona pellucida in the presence of human ZP2 (plus mouse ZP1 and 3), but not in the presence of human ZP3 (plus mouse ZP1 and 2).
The researchers next honed in on a region of ZP2 necessary for sperm binding, a region between amino acids 51-149 at the Nterminus of the protein. Chimeric experiments with mouse and human sequences showed that this region accounted for the phenomenon of species-specific sperm recognition. The mouse Nterminus bound mouse sperm, and the human N-terminus bound only human sperm. Mice lacking only the N-terminus of ZP2 were sterile.
The findings provide support for a model of fertilization in which sperm bind to the N-terminus of ZP2 prior to penetrating the egg. Previous studies have shown that after fertilization, the oocyte releases the protease ovastacin, which chews up the N-terminus of ZP2 to block sperm binding and prevent polyspermy. The new findings also have implications for the development of non-hormonal contraceptives that could potentially block the interaction of sperm with ZP2. In a study with major implications for the field of fertility preservation, researchers have successfully removed ovaries from sheep, frozen them, and then transplanted them back. In one protocol, 14 out of 14 ewes experienced restoration of ovarian function, nine of them became pregnant, and four gave birth-a solid achievement for a procedure where success has been spotty at best.
Premature ovarian failure, often caused by chemotherapy or genetics, affects 1 to 2 percent of women. In the last decade, options for such individuals have been increasing. Oocyte cryopreservation is now readily available, and some women and girls may also have access to a procedure involving cryopreservation of a slice of ovarian tissue-a procedure that has so far resulted in about 25 live births.
For years, researchers have also been working on another optionpreservation of an entire ovary. Researchers have been encouraged by sporadic findings, such as a live birth from a lamb that had undergone the procedure. But the technique suffers from a drawback that limits cryopreservation of all solid organs-when the organ thaws, ice damage to the vasculature causes blood clots, which choke off oxygen supplies.
To address this problem, Bruce Campbell and collaborators treated ewes with a cocktail of anti-coagulants immediately after transplantation. The researchers also tested two cryoprotectant protocols involving different perfusion times. A 60-minute perfusion time, combined with anticoagulant therapy, produced the best resultsovarian function was preserved in the 14 ewes. About 70 percent of the ovarian follicles survived, which would translate to sufficient ovarian reserve for a longer window of fertility in women than the approximately 5 years granted by autografting of the ovarian cortex.
Optimization of the dosage of anticoagulants, and other animal experiments, are needed before the new procedure can be tested in people. In addition to providing a potential new way to preserve fertility, the findings should also be of interest to researchers studying how to freeze other solid organs. 
